Health Care

U.S. Drugmaker Turing to Roll Back 5,000% Price Hike

Turing Pharmaceuticals, a small company that generated outrage over raising the cost of an old anti-infective drug by more than 5,000%, said on Tuesday it would roll back that increase to make sure it remains affordable.

Amgen to Help Develop Novartis's Pipeline of Alzheimer's Drugs

Novartis AG will share the risks and rewards as Amgen Inc. will help develop its pipeline of experimental Alzheimer's disease drugs, in a move that is becoming increasingly commonplace among drug makers eager to address the difficult-to-treat condition.

Juno Shares Surge on Collaboration Pact With Celgene

Celgene Corp. will make an initial payment of about $1 billion, including a stock purchase, as part of a 10-year collaboration with fellow biotech company Juno Therapeutics Inc. on cancer and autoimmune disease treatments.

Medical Marijuana: Evolution Revolution?

Scientists are mapping the Cannabis genome to increase understanding of the versatile plant’s many mutations, a marijuana version of the hugely influential Human Genome Project.

The End of AIDS—Are We Any Closer?

NIH’S top doctor talks candidly about his fight for an AIDS-Free Generation and the ‘breathtaking’ advances we’ve made in treatments.

A Wonder Drug for Opioid Overdose

U.S. Deaths are spiking from overdose related to heroin, Vicodin and OxyContin. But there is hope, as a drug called naloxone (aka Narcan) has been effective in keeping people alive following an OD.

Go Online To See Savings on Glasses

Vision insurance plans can help defray some of the costs associated with prescription eyeglasses, but it’s not going to cover it all. Look online.